Cencora's 2026 Pharmacy Outlook highlights benchmarking data on specialty, 340B, infusion, and more from 100+ health system pharmacy leaders. At over 60 pages, this flagship thought leadership asset -- distributed in print and electronic form -- is key to how the company positions itself as a strategic health systems partner.
The project behind this publication began with an extraordinarily short four-month timeline that involved creating a multi-question survey emailed to leaders at regional health systems, community hospitals, integrated delivery networks, ambulatory centers, and critical access hospitals across the U.S. with an average pharmacy spend of $144.8M.
In addition to helping craft and proof survey questions, my role involved developing an outline of the entire report; coordinating review of survey results with six different teams representing areas reflected in the results; interviewing dozens of team members about what the results represent; and then writing and editing copy and managing revisions by a cross-functional team of subject matter experts and marketers. After proofing the layout and design, I partnered with multiple internal stakeholders to help shepherd it through Cencora's extensive internal review/approval process.
In the end, we partnered with the respected industry outlet Becker's Healthcare to publish it on their website and distribute via their pharmacy e-newsletter (reaching over 12,000 subscribers).
Per executive feedback, the leads that came from Becker's alone were more than the entire year for all of Cencora's Human Health division in 2025.
Click here to view the 2026 Pharmacy Outlook as a .pdf.
Comments
Post a Comment